Net Assets for Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's latest reported net assets is $18.26B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
BIIB
Currently viewingNet AssetsSwitch metric
Latest period
$18.26B
YoY change
+9.2%
5Y CAGR
+11.3%
Peak year (2025)
$18.26B
Latest annual
$18.26B
Net Assets history chart for Biogen (BIIB) from 1985 to 2025
Net Assets history table for Biogen (BIIB) from 1985 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $18.26B | +9.2% | ||
| 2024 | $16.72B | +13.0% | ||
| 2023 | $14.80B | +10.5% | ||
| 2022 | $13.40B | +23.0% | ||
| 2021 | $10.90B | +1.8% | ||
| 2020 | $10.70B | -19.8% | ||
| 2019 | $13.34B | +2.3% | ||
| 2018 | $13.04B | +3.4% | ||
| 2017 | $12.61B | +3.9% | ||
| 2016 | $12.14B | +29.5% | ||
| 2015 | $9.37B | -13.3% | ||
| 2014 | $10.81B | +25.4% | ||
| 2013 | $8.62B | +23.8% | ||
| 2012 | $6.96B | +8.3% | ||
| 2011 | $6.43B | +19.1% | ||
| 2010 | $5.40B | -13.3% | ||
| 2009 | $6.22B | +7.2% | ||
| 2008 | $5.81B | +4.9% | ||
| 2007 | $5.53B | -22.6% | ||
| 2006 | $7.15B | +3.5% | ||
| 2005 | $6.91B | +1.2% | ||
| 2004 | $6.83B | -3.2% | ||
| 2003 | $7.05B | +342.1% | ||
| 2002 | $1.60B | +18.3% | ||
| 2001 | $1.35B | +21.9% | ||
| 2000 | $1.11B | +13.0% | ||
| 1999 | $979.53M | +36.3% | ||
| 1998 | $718.61M | +34.0% | ||
| 1997 | $536.29M | +10.7% | ||
| 1996 | $484.37M | +26.5% | ||
| 1995 | $382.98M | +16.1% | ||
| 1994 | $329.93M | +1.5% | ||
| 1993 | $325.20M | +14.1% | ||
| 1992 | $285.00M | +19.2% | ||
| 1991 | $239.00M | +64.0% | ||
| 1990 | $145.70M | +4.7% | ||
| 1989 | $139.20M | +104.7% | ||
| 1988 | $68.00M | +0.1% | ||
| 1987 | $67.90M | -24.0% | ||
| 1986 | $89.30M | +19.2% | ||
| 1985 | $74.90M | — |
Net Assets values are taken from Biogen's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Biogen (BIIB) reported net assets of $18.26B – grew 9.2% year-over-year.
Biogen net assets compound annual growth for the 2020–2025 (5 years) window is +11.3%, sustaining 5 straight years of year-over-year growth.
The highest annual net assets of $18.26B was reported in 2025. The lowest in the available history was $67.90M in 1987.
Within Healthcare, Biogen (BIIB) ranks 7th among 8 peers we track. The peer median for net assets is $50.64B.
Biogen Net Assets by Year
Biogen Net Assets 2025: $18.26B
Biogen net assets in 2025 was $18.26B, grew 9.2% from 2024. This figure represents the highest annual value in the available history.
Biogen Net Assets 2024: $16.72B
Biogen net assets in 2024 was $16.72B, grew 13.0% from 2023.
Biogen Net Assets 2023: $14.80B
Biogen net assets in 2023 was $14.80B, grew 10.5% from 2022.
Biogen Net Assets 2022: $13.40B
Biogen net assets in 2022 was $13.40B, grew 23.0% from 2021.
Biogen Net Assets 2021: $10.90B
Biogen net assets in 2021 was $10.90B.
See more financial history for Biogen (BIIB).
Sector peers — Net Assets
Companies in the same sector as Biogen, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Biogen's net assets?
- Latest reported net assets for Biogen (BIIB) is $18.26B (period ending December 31, 2025).
How has Biogen net assets changed year-over-year?
- Biogen (BIIB) net assets changed +9.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Biogen net assets?
- Biogen (BIIB) net assets compound annual growth rate is +11.3% over the most recent 5 years available.
When did Biogen net assets hit its highest annual value?
- Biogen net assets reached its highest annual value of $18.26B in 2025.
What was Biogen net assets in 2024?
- Biogen (BIIB) net assets in 2024 was $16.72B.
What was Biogen net assets in 2025?
- Biogen (BIIB) net assets in 2025 was $18.26B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BIIB Overview
Company profile, financial tools, and key metrics
BIIB Revenue Counter
Earns $311.09 every second. See per minute, hour, and day.
BIIB Earnings Counter
Earns $41.01 per second net profit. See per minute, hour, and day.
BIIB Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
BIIB What If Invested
What if you had invested $1,000? See historical returns from any date.
BIIB How It Makes Money
Discover visual breakdown of $9.81B in revenue — where it comes from and where it goes.
BIIB Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BIIB Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BIIB Daily Price Character
Explosive · 48.1% historical win rate (green days). Streaks & record days.
BIIB Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BIIB Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.